Our Solutions   Lornoxi P Tablets

Lornoxi P Tablets

Lornoxi P Tablet

*To be consumed as directed by physician.

Therapies:

Pain Management

Composition:

Lornoxicam (8 mg) + Paracetamol / Acetaminophen (500 mg)

About Lornoxi P Tablet

Lornoxi – P Tablets is a blend of Lornoxicam and Paracetamol, manufactured to deliver dual action relief from pain and inflammation. Lornoxicam is an NSAID; it works by inhibiting cyclooxygenase enzymes to reduce prostaglandin synthesis, while paracetamol acts centrally to ease pain and lower fever. Together, they offer more comprehensive pain management than either molecule alone, making Lornoxi-P an effective option for moderate-to-severe pain conditions.

Lornoxi P Tablet

*To be consumed as directed by physician.


Usage Instructions

  • Take Lornoxi-P Tablets exactly as directed by your healthcare professional.
  • Swallow the Tablets whole with water and avoid exceeding the recommended dosage.
  • For best results, follow the prescribed schedule consistently and consult your doctor if symptoms persist or worsen.
  • Keep the medication out of children's reach.

Benefits and Use

  • Lornoxi-P Tablets provides targeted, multi-mechanism relief across a range of painful conditions.
  • Lornoxicam reduces joint swelling, stiffness, and inflammation characteristic of rheumatoid arthritis and osteoarthritis, while Paracetamol simultaneously lowers fever and reinforces analgesic action.
  • The combination is effective in post-surgical pain management, acute musculoskeletal pain, and spondylitis-related discomfort.
  • Patients benefit from faster-onset relief, improved joint mobility, and better day-to-day functioning throughout the course of treatment.

Safety Information

  • Pregnancy
    Lornoxi-P Tablets is not recommended during pregnancy, particularly in the third trimester, as NSAIDs like Lornoxicam may cause premature closure of the ductus arteriosus and fetal renal complications. Consult your obstetrician before using this medication if you are pregnant or planning a pregnancy.
  • Breastfeeding
    The use of Lornoxi-P Tablets is not advisable in nursing mothers, as the active ingredients may pass into breast milk and potentially affect the infant. Seek medical advice before taking this medicine during the lactation period.
  • Alcohol
    Intake of alcohol with Lornoxi-P Tablets significantly increases the risk of gastrointestinal bleeding, liver stress, and central nervous system adverse effects such as dizziness or drowsiness. Alcohol must be strictly avoided during this treatment.
  • Kidney Disorders
    Lornoxi-P Tablets is contraindicated in patients with severe renal impairment, as NSAIDs can further reduce renal perfusion and worsen kidney function. Patients with mild to moderate kidney disease should use this medication only under close medical supervision with regular monitoring.
  • Lung Disorders
    Patients with a history of NSAID-induced bronchospasm, asthma, or aspirin-sensitive respiratory conditions should use Lornoxi-P Tabletswith caution, as it may precipitate or aggravate breathing difficulties. Inform your doctor about any pre-existing pulmonary conditions before initiating therapy.

Ingredients

Lornoxicam (8 mg) + Paracetamol (325 mg)

How to Use

  • Take Lornoxi-P Tablets as prescribed by your doctor, preferably after food to help minimise stomach discomfort.
  • Swallow the Tablets whole with a glass of water and do not crush, chew, or break it unless advised by a healthcare professional.

Storage Information

Store below 25°C